| Literature DB >> 24532806 |
Jessica L Allen1, Prasanthi V Tata, Matthew S Fore, Jenna Wooten, Sharmistha Rudra, Allison M Deal, Andrew Sharf, Todd Hoffert, Philip A Roehrs, Thomas C Shea, Jonathan S Serody, Kristy L Richards, Madan Jagasia, Stephanie J Lee, David Rizzieri, Mitchell E Horwitz, Nelson J Chao, Stefanie Sarantopoulos.
Abstract
Although B cells have emerged as important contributors to chronic graft-versus-host-disease (cGVHD) pathogenesis, the mechanisms responsible for their sustained activation remain unknown. We previously showed that patients with cGVHD have significantly increased B cell-activating factor (BAFF) levels and that their B cells are activated and resistant to apoptosis. Exogenous BAFF confers a state of immediate responsiveness to antigen stimulation in normal murine B cells. To address this in cGVHD, we studied B-cell receptor (BCR) responsiveness in 48 patients who were >1 year out from allogeneic hematopoietic stem cell transplantation (HSCT). We found that B cells from cGVHD patients had significantly increased proliferative responses to BCR stimulation along with elevated basal levels of the proximal BCR signaling components B cell linker protein (BLNK) and Syk. After initiation of BCR signaling, cGVHD B cells exhibited increased BLNK and Syk phosphorylation compared with B cells from patients without cGVHD. Blocking Syk kinase activity prevented relative post-HSCT BCR hyper-responsiveness of cGVHD B cells. These data suggest that a lowered BCR signaling threshold in cGVHD associates with increased B-cell proliferation and activation in response to antigen. We reveal a mechanism underpinning aberrant B-cell activation in cGVHD and suggest that therapeutic inhibition of the involved kinases may benefit these patients.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24532806 PMCID: PMC3968393 DOI: 10.1182/blood-2013-10-533562
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113